'); $("#expandable-weather-block .modal-body #mrd-alert"+ alertCount).append(""+val.title+""); // if (window.location.hostname == "www.kmov.com" || window.location.hostname == "www.kctv5.com" || window.location.hostname == "www.azfamily.com" || window.location.hostname == "www.kptv.com" || window.location.hostname == "www.fox5vegas.com" || window.location.hostname == "www.wfsb.com") { if (val.poly != "" && val.polyimg != "") { $("#expandable-weather-block .modal-body #mrd-alert"+ alertCount).append('"+val.ihtml+""); $("#expandable-weather-block .weather-index-alerts").show(); $("#expandable-weather-block .modal-body h2").css({"font-family":"'Fira Sans', sans-serif", "font-weight":"500", "padding-bottom":"10px"}); $("#expandable-weather-block .modal-body p").css({"font-size":"14px", "line-height":"24px"}); $("#expandable-weather-block .modal-body span.wxalertnum").css({"float":"left", "width":"40px", "height":"40px", "color":"#ffffff", "line-height":"40px", "background-color":"#888888", "border-radius":"40px", "text-align":"center", "margin-right":"12px"}); $("#expandable-weather-block .modal-body b").css("font-size", "18px"); $("#expandable-weather-block .modal-body li").css({"font-size":"14px", "line-height":"18px", "margin-bottom":"10px"}); $("#expandable-weather-block .modal-body ul").css({"margin-bottom":"24px"}); $("#expandable-weather-block .modal-body pre").css({"margin-bottom":"24px"}); $("#expandable-weather-block .modal-body img").css({"width":"100%", "margin-bottom":"20px", "borderWidth":"1px", "border-style":"solid", "border-color":"#aaaaaa"}); $("#expandable-weather-block .modal-body #mrd-alert"+ alertCount).css({"borderWidth":"0", "border-bottom-width":"1px", "border-style":"dashed", "border-color":"#aaaaaa", "padding-bottom":"10px", "margin-bottom":"40px"}); }); } function parseAlertJSON(json) { console.log(json); alertCount = 0; if (Object.keys(json.alerts).length > 0) { $("#mrd-wx-alerts .modal-body ").empty(); } $.each(json.alerts, function(key, val) { alertCount++; $("#mrd-wx-alerts .alert_count").text(alertCount); $("#mrd-wx-alerts .modal-body ").append(''); $("#mrd-wx-alerts .modal-body #mrd-alert"+ alertCount).append(""+val.title+""); // if (window.location.hostname == "www.kmov.com" || window.location.hostname == "www.kctv5.com" || window.location.hostname == "www.azfamily.com" || window.location.hostname == "www.kptv.com" || window.location.hostname == "www.fox5vegas.com" || window.location.hostname == "www.wfsb.com") { if (val.poly != "" && val.polyimg != "") { $("#mrd-wx-alerts .modal-body #mrd-alert"+ alertCount).append(''); } else if (val.fips != "" && val.fipsimg != "") { // $("#mrd-wx-alerts .modal-body #mrd-alert"+ alertCount).append(''); } // } //val.instr = val.instr.replace(/[W_]+/g," "); $("#mrd-wx-alerts .modal-body #mrd-alert"+ alertCount).append(val.dhtml+"
Instruction
`;articleContent = document.querySelector(".article-content");articleContent.innerHTML = articleContent.innerHTML + formbox;function waitForElement(id, callback){ var goStahp = setInterval(function(){ if(document.getElementById(id)){ clearInterval(goStahp); callback(); } }, 100);}waitForElement("JotFormIFrame-202185815209151", function(){var ifr = document.getElementById("JotFormIFrame-202185815209151"); if(window.location.href && window.location.href.indexOf("?") > -1) { var get = window.location.href.substr(window.location.href.indexOf("?") + 1); if(ifr && get.length > 0) { var src = ifr.src; src = src.indexOf("?") > -1 ? src + "&" + get : src + "?" + get; ifr.src = src; } } window.handleIFrameMessage = function(e) { if (typeof e.data === 'object') { return; } var args = e.data.split(":"); if (args.length > 2) { iframe = document.getElementById("JotFormIFrame-" + args[(args.length - 1)]); } else { iframe = document.getElementById("JotFormIFrame"); } if (!iframe) { return; } switch (args[0]) { case "scrollIntoView": iframe.scrollIntoView(); break; case "setHeight": console.log(`case: setHeight`); iframe.style.height = parseInt(args[1]) + 15 + "px"; break; case "collapseErrorPage": console.log(`case: collapseErrorPage`); if (iframe.clientHeight > window.innerHeight) { iframe.style.height = window.innerHeight + "px"; } break; case "reloadPage": window.location.reload(); break; case "loadScript": var src = args[1]; if (args.length > 3) { src = args[1] + ':' + args[2]; } var script = document.createElement('script'); script.src = src; script.type = 'text/javascript'; document.body.appendChild(script); break; case "exitFullscreen": if (window.document.exitFullscreen) window.document.exitFullscreen(); else if (window.document.mozCancelFullScreen) window.document.mozCancelFullScreen(); else if (window.document.mozCancelFullscreen) window.document.mozCancelFullScreen(); else if (window.document.webkitExitFullscreen) window.document.webkitExitFullscreen(); else if (window.document.msExitFullscreen) window.document.msExitFullscreen(); break; } var isJotForm = (e.origin.indexOf("jotform") > -1) ? true : false; if(isJotForm && "contentWindow" in iframe && "postMessage" in iframe.contentWindow) { var urls = {"docurl":encodeURIComponent(document.URL),"referrer":encodeURIComponent(document.referrer)}; iframe.contentWindow.postMessage(JSON.stringify({"type":"urls","value":urls}), "*"); } }; if (window.addEventListener) { window.addEventListener("message", handleIFrameMessage, false); } else if (window.attachEvent) { window.attachEvent("onmessage", handleIFrameMessage); }});//
`;articleContent = document.querySelector(".article-content");articleContent.innerHTML = articleContent.innerHTML + formbox;function waitForElement(id, callback){ var goStahp = setInterval(function(){ if(document.getElementById(id)){ clearInterval(goStahp); callback(); } }, 100);}waitForElement("JotFormIFrame-202185815209151", function(){var ifr = document.getElementById("JotFormIFrame-202185815209151"); if(window.location.href && window.location.href.indexOf("?") > -1) { var get = window.location.href.substr(window.location.href.indexOf("?") + 1); if(ifr && get.length > 0) { var src = ifr.src; src = src.indexOf("?") > -1 ? src + "&" + get : src + "?" + get; ifr.src = src; } } window.handleIFrameMessage = function(e) { if (typeof e.data === 'object') { return; } var args = e.data.split(":"); if (args.length > 2) { iframe = document.getElementById("JotFormIFrame-" + args[(args.length - 1)]); } else { iframe = document.getElementById("JotFormIFrame"); } if (!iframe) { return; } switch (args[0]) { case "scrollIntoView": iframe.scrollIntoView(); break; case "setHeight": console.log(`case: setHeight`); iframe.style.height = parseInt(args[1]) + 15 + "px"; break; case "collapseErrorPage": console.log(`case: collapseErrorPage`); if (iframe.clientHeight > window.innerHeight) { iframe.style.height = window.innerHeight + "px"; } break; case "reloadPage": window.location.reload(); break; case "loadScript": var src = args[1]; if (args.length > 3) { src = args[1] + ':' + args[2]; } var script = document.createElement('script'); script.src = src; script.type = 'text/javascript'; document.body.appendChild(script); break; case "exitFullscreen": if (window.document.exitFullscreen) window.document.exitFullscreen(); else if (window.document.mozCancelFullScreen) window.document.mozCancelFullScreen(); else if (window.document.mozCancelFullscreen) window.document.mozCancelFullScreen(); else if (window.document.webkitExitFullscreen) window.document.webkitExitFullscreen(); else if (window.document.msExitFullscreen) window.document.msExitFullscreen(); break; } var isJotForm = (e.origin.indexOf("jotform") > -1) ? true : false; if(isJotForm && "contentWindow" in iframe && "postMessage" in iframe.contentWindow) { var urls = {"docurl":encodeURIComponent(document.URL),"referrer":encodeURIComponent(document.referrer)}; iframe.contentWindow.postMessage(JSON.stringify({"type":"urls","value":urls}), "*"); } }; if (window.addEventListener) { window.addEventListener("message", handleIFrameMessage, false); } else if (window.attachEvent) { window.attachEvent("onmessage", handleIFrameMessage); }});//
The memo reflects the CDCs priority rubric for group 1b, which informs our plans along with the more specific guidance from the city of Philadelphia that outlines when individuals in specific jobs within our academic health system, or based on age and pre-existing conditions and other factors, can be vaccinated, Brennan said. There are multiple, evolving layers of guidance from the federal, state, and city level, and we continue to adapt our plans accordingly and collaborate closely with the city. We are united in our shared goals to ensure that all available vaccine is given to priority groups.
We know there are a lot of questions about the coronavirus vaccine, including where to get it, so we put together information and resources in one place to help you.
NORFOLK, Va. If all the information about the COVID-19 seems a little overwhelming, we hear you. There's a lot out there, along with a pile of questions and some confusion. We put this together as a one-stop destination to help. We'll update it with more information as we get it.
Virginia
Virginia Department of Health has a series of questions you can answer to help you find out when you can get vaccinated. You also can sign up to be notified when you're eligible to get vaccinated.
COVID-19 Vaccine Phases
Hampton Roads and the Eastern Shore
Here's a list of the current phases in which the Virginia Department of Health says cities and counties in Hampton Roads and on the Eastern Shore are:
North Carolina
The North Carolina Department of Health and Human Services put together a tool to help people "find your spot to take your shot."
COVID-19 Vaccine Groups
Frequently Asked Questions
North Carolina put together a list of questions people have about the vaccine, itself, as well as getting vaccinated in the state:
Patton State Hospital to vaccinate all patients against COVID-19 by this week amid major outbreak San Bernardino County Sun
Both Pfizer and Moderna's COVID-19 vaccines require two shots to reach the maximum level of protection against the virus. Are the two doses different?
ROCK HILL, S.C. State health agencies collectively report tens of thousands of people in the Carolinas are now considered "fully vaccinated," meaning they have received two doses of either the Pfizer or the Moderna vaccine.
The companies report both their vaccines are roughly 95% effective in preventing the virus, but a person needs two shots to get that level of protection.
Is there a difference between dose one and dose two of the currently approved COVID-19 vaccines?
The first dose and second dose of your Pfizer or Moderna COVID-19 vaccine should be exactly the same, both chemically and from a dosage standpoint.
According to the manufacturer's instructions for the two approved vaccines, Pfizer and Moderna, doses must be spaced apart.
For Pfizer, it's three weeks between doses. For Moderna, it's one month.
However, each manufacturer only provides one set of instructions, with no difference in directions between dose one and dose two.
Moderna's instructions read: "The Moderna COVID-19 Vaccine is administered intramuscularly as a series of two doses (0.5 mL each) 1 month apart."
Pfizer's instructions read: "The Pfizer-BioNTech COVID-19 Vaccine is administered intramuscularly as a series of two doses (0.3 mL each) 3 weeks apart."
Dr. Brannon Traxler, Interim Public Health Director with South Carolina's Department of Health and Environmental Control, confirms there is no difference between the two doses.
"They are exactly the same, in terms of the chemical makeup, but what they do and their function is a little bit different," Traxler said.
Traxler states the function of dose one is that of a primer.
"It gets (the immune system) ready and gets it started -- so, making antibodies and producing that immune response," Traxler said. "Then, the second dose --which again, in the syringe is identical -- but it is a booster. It boosts your immune system's response to more significantly produce antibodies."
Premier Doug Ford is set to provide an update on the provinces COVID-19 vaccination plan Tuesday afternoon.
The press conference comes after it was announced on Monday that a pilot COVID-19 vaccination clinic at the Metro Toronto Convention Centre will have to pause vaccinations on Friday because of a shortage of vaccine supply in the province.
We were all disappointed to learn that the delivery of Pfizer vaccine to Canada is expected to be delayed as a result of manufacturing delays in Europe. As a result, we have now been advised by the province that we will only be able to operate this proof of concept clinic for an initial five days due to the lack of availability of COVID-19 vaccine, Toronto Fire Chief Matthew Pegg said at the citys media briefing on Monday.
The proof-of-concept clinic opened on Monday and is supposed to serve as a guideline for how shots should be administered in non-medical settings starting this spring.
Pegg said anyone with an appointment at the clinic from Jan. 23 onwards should expect that their appointment will be cancelled
The site had been expected to run for at least six weeks with an initial target of 250 doses per day.
The clinic will resume vaccinations once the province gives it the green light.
All Canadian provinces are anticipating a month of reduced Pfizer COVID-19 vaccine shipments after the company told clients, including Canada and the European Union, it was retooling several plants to increase production, leading to production shortfalls.
Since mid-December, COVID-19 vaccines have only been administered at long-term care homes and at 19 hospital sites across Ontario.
As of Sunday at 8 p.m., the province had administered more than 209,700 doses of both the Pfizer-BioNTech and Moderna COVID-19 vaccines.
A total of 21,752 people have been fully vaccinated so far as two doses of the vaccine are required for full immunization.
Ford, along with Minister of Health Christine Elliott, Minister of Long-Term Care Merrilee Fullerton, Solicitor General Sylvia Jones, and chair of the provinces COVID-19 vaccine task force retired General Rick Hillier, will speak today at 1 p.m.
CP24.com will carry that announcement live.
Can people who get the coronavirus vaccine still be contagious? The story of sterilizing immunity. Salt Lake Tribune
BERLIN (Reuters) - German pharmaceutical giant Bayer is examining whether it can help CureVac to produce its experimental COVID-19 vaccine, its chief executive was quoted as saying on Sunday.
Though inoculation campaigns have started around the world using various COVID-19 vaccines, many countries say their ability to get shots into arms is being limited by lower than expected supplies owing to a shortage of production.
We are prepared to pull out all the stops for this, Werner Baumann told the Welt am Sonntag newspaper.
This is not primarily about financial considerations but about making the vaccine available as quickly as possible.
Bayer agreed this month to help fellow German company CureVac with development of its COVID-19 vaccine candidate, which is in late-stage clinical trials and has not yet been approved.
Baumann said the drugmaker was intensively examining whether to expand its co-operation to include manufacturing the vaccine for CureVac.
With our production network in Germany and the USA and the corresponding lead time, we would in principle be in a position to produce vaccine in larger quantities, he said.
On Friday U.S. drugmaker Pfizer said there would be a temporary slowdown of shipments of the vaccine it developed with German partner BioNTech, citing changes in manufacturing processes to boost output.
Reporting by Caroline Copley; Editing by David Goodman
